Underhill Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Underhill Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$365K	Buy	+7,650	New	+$381K	0.19%	19

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Underhill Investment Management's BMY Position: Q1 2019 in Review

Underhill Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2019: 7,650 shares worth $365K. The stake represents 0.19% of the portfolio and ranks #19 among its holdings.

1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Underhill Investment Management held 7,650 shares of Bristol-Myers Squibb worth $365K as of Q1 2019.
Bristol-Myers Squibb was a new Underhill Investment Management position in Q1 2019.
Bristol-Myers Squibb made up 0.19% of Underhill Investment Management's portfolio in Q1 2019, its #19 holding.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Underhill Investment Management's 13F filing for Q1 2019, filed 5 Apr 2019.